Protective effect of Matricaria Chamomilla extract on hepatic-renal toxicity of ceftriaxone in rats

 
 
 
  • Abstract
  • Keywords
  • References
  • PDF
  • Abstract


    The effect of Matricaria chamomilla (M.chamomilla) against hepatic-renal toxicity of Ceftriaxone was investigated in this study. Twenty eight rats were divided into four groups. The 1st group was injected with saline as control, the 2nd  and 3rd  groups were injected with M.chamomilla extraction ( 50mg/kg.b.wt) and with ceftriaxone ( 180 mg/kg.b.wt.) for two and one week respectively while the 4th  group was injected with M.chamomilla extraction plus ceftriaxone. at dose 50mg/kg and 180 mg/kg.b.wt respectively ,daily for the one week and with M.chamomilla extraction only at dose 50mg/kg.b.wt for another week. At the end of the 1st  week, the 3rd group had significantly higher ALP,ALT,AST, urea and creatinine levels with significantly lower albumin and A/G ratio levels than that of the 1st and 2nd groups , while the 4th  group did not differ from 1st and 2nd groups in terms of these parameters. Histopathological studies revealed that, the 3rd  group had some pathological changes in the liver and kidney.From this study we can conclude that, M. chamomilla extraction  can reduce hepatic-renal toxicity of ceftriaxone in rats.


  • Keywords


    Ceftriaxone; Matricaria Chamomilla; Biochemical Changes; Histopathological.

  • References


      [1] Avci Z, Koktener A, Uras N, Catal F, Karadag A, Tekin O& et al. (2016) Nephrolithiasis associated with ceftriaxone therapy: a prospective study in 51 children. Arch Dis Child 2004. 89: 1069-1072.https://doi.org/10.1136/adc.2003.044156.

      [2] Bakul KD, Sanjib K, Aditi C, Tapan K, Mandal., Animesh K & et al. (2009) Long Term Effect Of Ceftriaxone In Black Bengal Goats After Repeated Intramuscular Administration. Pharmacologyonline. 3: 376-393

      [3] Bhamidimarri K & Eugene S (2013) Drug-Induced Cholestasis. Clin Liver Dis. 17 : 519- 531https://doi.org/10.1016/j.cld.2013.07.015.

      [4] Bourget P, Fernandez H&Quinquis V (1993) Pharmacokinetics and Protein binding of ceftriaxone during pregnancy. Antibiotic Agents and Chemotherapy. 37: 54-59 https://doi.org/10.1128/AAC.37.1.54.

      [5] Carnat A, Carnat A, P., Fraisse D, Ricoux L&Lamaison J, L (2004) theaeromatic and polyphenolic composition of Roman camomile tea. Fitoterapia. 75 : 32-38.https://doi.org/10.1016/j.fitote.2003.07.007.

      [6] El-Sayed M, G., Hassanin. & Hafez M, R (1997) somepharmacodynamic and biochemical aspects of cefamandole. DtschTierarztlWochenschr. 104(11): 481-487.

      [7] Elsayed M, ElkomyA&Aboubakr M (2011a) Hepatotoxicity evaluation in albino rats exposed to ceftriaxone. Asian J Phar Biol Res. 1: 145-150.

      [8] Elsayed MG, ElkomyA&Aboubakr M (2011b) Evaluation of ceftriaxone nefrotoxicity in albino rats. IJAVMS. 5(2): 153-163.https://doi.org/10.5455/ijavms.20110513094308.

      [9] Fabian D, Juhás2 S, Bukovská A, Bujňáková D, Grešáková L& Koppel J (2011) Anti-Inflammatory Effects Of Chamomile Essential Oil In Mice. Slovak J. Anim. Sci. 44(3): 111-116

      [10] Gaw A, Cowan R, O’Reilly D, Stewart M& Shepherd J (1999) Clinical biochemistry an illustrated color text.1st ed .New York:Churchill Livingstone:51-53

      [11] Gillian J, Gonard V, Dalmasso C &Palixc C (1987) Bilirubin displacement by ceftriaxone in neonates: evaluation by determination of'free' bilirubin and erythrocyte bound dose pharmacokinetics of ceftriaxone in bilirubin. Journal of Antimicrobial Chemotherapy. 19: 823-829.https://doi.org/10.1093/jac/19.6.823.

      [12] Glick M, R., Ryder KW& Jackson S A (1986) Graphical Comparison of interferances in clinical chemistry instrumentation. Clin. Chem. 32: 470-474

      [13] Gohil PV, Patel UD, Bhavsar SK &ThakerAM (2009) Pharmacokinetics of ceftriaxone in buffalo calves (Bubalusbubalis) following intravenous and intramuscular administration. Iranian Journal of Veterinary Research, Shiraz University. 10(1): 26

      [14] Janmejai K, S., Eswar S &Saanjay G (2010) Chamomile:A herbal medicine of the past with a bright future. Mol Med Report. 1(3(6)): 896-901

      [15] Khaled AA, Sally AE-A, Wafaa IE-I&Ezz-El-Din SE-D (2014) Protective effects of ursodeoxycholic acid on ceftriaxone-induced hepatic injury in rats. Bulletin of Faculty of Pharmacy, Cairo University.52: 45-50.https://doi.org/10.1016/j.bfopcu.2014.02.002.

      [16] Kohda Y, Matsunaga Y&Yonogi K (2005) Protective effect of serum thymic factor, FTS, on cephaloridine-induced nephrotoxicity in rats. Biol Pharm Bull. 28(11): 2087-2091https://doi.org/10.1248/bpb.28.2087.

      [17] Maier S, M., Gross J, K., Hamlin K, L., Maier J, L., Workman J, L., Kim H& et al. (2007) Proteinuria of nonautoimmune origin in wild -type FVB/NJ mice. Comp.Med. 57: 255-266

      [18] Malomo S (2000). Toxicological implications of ceftriaxone administration in rats. Nig J BiochemMol Biol. 15: 33-38

      [19] Matsuzaki K, Shito K, Watabe E, Hasegawa M, Sato Y& Kobayashi I (2005) Antibacterial activity of ceftriaxone against various clinical strains isolated in 2004. Jpn,JAntibiot. 58 : 283-289

      [20] McKay D, L & Blumberg J B (2006) A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.). Phytother Res. 20: 519-530.https://doi.org/10.1002/ptr.1900.

      [21] Moss D& Butterworth P (1974) Enzymology and medicine. London: Pitman Medical

      [22] Neu H C (1985) Relation of structural properties of beta-lactamantibiotics to antibacterial activity. Am J Med. 79: 2-13.https://doi.org/10.1016/0002-9343(85)90254-2.

      [23] Nnodim J, Emejulu A, AmaechiA&NwosuNjoku E (2010) Alterations in biochemical parameters of Wistar rats administered with sulfadoxine and pyrimethamine (Fansidar). Al Ameen J Med Sci. 3: 317-321

      [24] Ogata I, Kawanai T, Hashimoto E, Nishimura Y, Oyama Y&Seo H (2010) Bisabololoxide A, one of the main constituents in German chamomile extract, induces apoptosis in rat thymocytes. Arch Toxicol. 84: 45-52.https://doi.org/10.1007/s00204-009-0472-5.

      [25] Park H, Z., Lee S P &Schy A L (1991). Ceftriaxone-associated gallbladder sludge.Identification of calcium-ceftriaxone salt as a major component of gallbladder precipitate. Gastroenterology. 100: 1665-1670.https://doi.org/10.1016/0016-5085(91)90667-A.

      [26] Ragaa HMS (2012) Matricaria chamomilla Attenuates Cisplatin Nephrotoxicity. Saudi J Kidney Dis Transpl. 23(4): 765-772https://doi.org/10.4103/1319-2442.98158.

      [27] Ragaa HMS, Nahed A A., Sary K A, Zaghloul T M&Nagwa M A G (2011). Nephroprotective Effect of Nigella sativa and Matricaria chamomilla in Cisplatin Induced Renal Injury. International Journal of Clinical Medicine. 2: 185-195.https://doi.org/10.4236/ijcm.2011.23031.

      [28] Rajpurohit H, Kumar V B, Sharadamma K &Radhakrishna P (2012) Comparative study of antimicrobial activity of ceftriaxone in combination with sulbactam and tazobactam using disc diffusion. Method. Int J Pharm. 3: 331-334.Ramkumar D.

      [29] LaBrecque D (2003) Drug-induced liver disease and environmental toxins. In: Zakim D, Boyer T, editors. Hepatology: a textbook of liver disease. Philadelphia: Saunders. 755-832

      [30] Reddy K & Schiff E (1995) Hepatotoxicity of antimicrobial, antifungal,andantiparasitic agents. GastroenterolClin North Am. 24:923-36).

      [31] Reitman S & Frankel S (1957) A calorimetric method for the determination of GOT and GPT. American J. of Clin.Pathol. 28: 56-63https://doi.org/10.1093/ajcp/28.1.56.

      [32] Saganuwan&Alhaji S (2006) Effects Of Ceftriaxone onHaematologicaland Biochemical Parameters of Turkey. Animal Research International. 3(3): 562-565.

      [33] Saleem TSM, Chetty CM, Ramkanth S, Rajan VST& Kumar KM (2010) Hepatoprotective Herbs – A Review. Int. J. Res. Pharm. Sci. 1(1): 1-5

      [34] Sar T, K., Mandal T K., Das S K, Chakraborty AK & Bhattacharyya A (2006) Pharmacokinotics of ceftriaxone in healthy and mastitic goats with special reference to its interaction with polyherbal drug (Fibrosin®). International journal of applied residue and veterinary medicine. 4(2): 142-154

      [35] Shiffman M L, Keith F B & Moore E W (1990) Pathogenesis of ceftriaxone-associated biliary sludge. In vitro studies of calcium-ceftriaxone binding and solubility. Gastroenterology. 99: 1772-1778.https://doi.org/10.1016/0016-5085(90)90486-K.

      [36] Shipochliev T, DimitrovA&Aleksandrova E (1981) Anti-inflammatory action of a group of plant extracts. Vet. Med. Nauki. 18: 87-94.

      [37] Srivastava J K, Pandey M &Gupta S (2009) Chamomile, a noval and selective Cox-2 inhibitor with anti-inflammatory activity. Life Sci. 85: 663-669.https://doi.org/10.1016/j.lfs.2009.09.007.

      [38] Sukhdev SH, Suman PSK, Gennaro L&Dev DR (2008) Extraction Technologies for Medicinal and Aromatic Plants. International Centre For Science And High Technology Trieste

      [39] Vandross R., Xue Y., Knudson A.&Pelling JC(2003) The chemopreventive bioflavonoid apigenin modulates signal transduction pathways in keratinocyte and colon carcinoma cell lines, J Nutr, 133 3800S-3804S

      [40] Verbeek R, Plomp Ac, Van TolEa&Van NoortJm (2004) The flavones luteolin and apigenin inhibit in vitro antigen-specific proliferation and interferon-gamma production by murine and human autoimmune T cells. Biochem. Pharmacol, 15: 621-629.https://doi.org/10.1016/j.bcp.2004.05.012.

      [41] Weichselbaum TE (1946) an a curate rapid for determination of protein small amount of blood serum and plasma. Am. J. Clin. Pathol.


 

View

Download

Article ID: 7249
 
DOI: 10.14419/ijpt.v5i1.7249




Copyright © 2012-2015 Science Publishing Corporation Inc. All rights reserved.